Showing results (1841-1850 of 1,858) with videos related to

Sort By:
Pageof 186
Breast Cancer Research and Treatment|April 2, 2026
Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trialManuel Hörner, Lara M Tretschock, Nelson John, et al.
Nature Geoscience|March 17, 2025
Anthropogenic organic aerosol in Europe produced mainly through second-generation oxidationMao Xiao, Mingyi Wang, Bernhard Mentler, et al.
NPJ Breast Cancer|April 11, 2026
PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer-Results from the prospective PRAEGNANT registryManuel Hörner, Andreas Hartkopf, Nelson John, et al.
Science Advances|September 8, 2023
Role of sesquiterpenes in biogenic new particle formationLubna Dada, Dominik Stolzenburg, Mario Simon, et al.
Orphanet Journal of Rare Diseases|July 12, 2022
Turner syndrome: French National Diagnosis and Care Protocol (NDCP; National Diagnosis and Care Protocol)Elodie Fiot, Bertille Alauze, Bruno Donadille, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2018
Rapid growth of organic aerosol nanoparticles over a wide tropospheric temperature rangeDominik Stolzenburg, Lukas Fischer, Alexander L Vogel, et al.
Nature Chemistry|November 14, 2022
The gas-phase formation mechanism of iodic acid as an atmospheric aerosol sourceHenning Finkenzeller, Siddharth Iyer, Xu-Cheng He, et al.
Cell|August 19, 2020
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell CompartmentJonas Schulte-Schrepping, Nico Reusch, Daniela Paclik, et al.
Brain : a Journal of Neurology|March 29, 2022
A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodiesChristine Strippel, Marisol Herrera-Rivero, Mareike Wendorff, et al.
The British Journal of Dermatology|July 21, 2016
Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)J R Chalmers, E Simpson, C J Apfelbacher, et al.
Pageof 186